Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.700
+0.150 (5.88%)
At close: Apr 2, 2026, 4:00 PM EDT
2.640
-0.060 (-2.22%)
After-hours: Apr 2, 2026, 7:55 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $194.97 million as of April 2, 2026. Its market cap has increased by 155.53% in one year.
Market Cap
194.97M
Enterprise Value
109.42M
1-Year Change
155.53%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $194.97M, a decrease of -68.47%. That is a compound annual growth rate of -21.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 194.97M | 52.55% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 201.92M |
| Nuvectis Pharma | 200.28M |
| Tonix Pharmaceuticals Holding | 197.46M |
| Elicio Therapeutics | 195.92M |
| MacroGenics | 195.12M |
| Jyong Biotech | 188.41M |
| Adagene | 188.05M |
| Caribou Biosciences | 187.48M |